Coal Tar Ointment
NDC Package 70666-016-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Coal Tar ointment is when using this product Avoid contact with the eyes. This formulation utilizes a ointment delivery system. Marketed by Nopsor Usa Distribution Co., Inc., this product is identified by NDC 70666-016 and is authorized under FDA application M032.

Identification & Billing

NDC Package Code
70666-016-04
Package Description
125 mL in 1 JAR
Product Code
70666-016
11-Digit Billing Format
70666001604

Clinical Specifications

Proprietary Name
Coal Tar
Non-Proprietary Name
Coal Tar
Substance Name
Coal Tar
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
COAL TAR 1.39 g/100mL
Usage Information
When using this product Avoid contact with the eyes. If contact occurs, rinse thoroughly with water. • Do not use this product with other forms of Psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed to do so by a physician. • If condition worsens or does not improve after regular use of this product as directed, consult a doctor. • Do not use for prolonged periods without consulting a physician. • If condition covers a large area of the body, consult your physician before using this product. • Use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application. Warning: This product contains chemicals known to the state of California to cause cancer. When using this product avoid contact with the eyes. If contact occurs, rinse thoroughly with water. • Do not use this product with other forms of Psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed to do so by a physician. • If condition worsens or does not improve after regular use of this product as directed, consult a doctor. • Do not use for prolonged periods without consulting a physician. • If condition covers a large area of the body, consult your physician before using this product. • Use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application. Warning: This product contains chemicals known to the state of California to cause cancer.

Regulatory & Marketing

Labeler Name
Nopsor Usa Distribution Co., Inc.
Product Type
Human Otc Drug
FDA Application #
M032
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-01-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70666-016-04 identifies a specific commercial package of 125 ml in 1 jar of Coal Tar, a human over the counter drug labeled by Nopsor Usa Distribution Co., Inc.. This ointment is formulated for topical use and contains coal tar as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nopsor Usa Distribution Co., Inc. on December 01, 2016. The current certification is valid through December 31, 2026.

How is this Nopsor Usa Distribution Co., Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70666001604. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70666-016-04
11-Digit CMS (5-4-2)
70666-0016-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.